查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1750777

静脉输液帮浦市场规模、份额、趋势分析报告：依产品、适应症、地区、细分市场预测，2025-2030 年

Intravenous Infusion Pumps Market Size, Share & Trends Analysis Report By Product (Volumetric Infusion Pumps, Syringe Infusion Pumps), By Disease Indication (Chemotherapy, Diabetes, Gastroenterology), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

静脉输液帮浦市场成长与趋势：

根据 Grand View Research, Inc. 的最新报告，全球静脉输液帮浦市场规模预计到 2030 年将达到 99.8 亿美元，预测期内的复合年增长率为 8.5%。

癌症、糖尿病、心血管疾病和呼吸系统疾病等慢性疾病的盛行率日益上升，需要精准的药物治疗和治疗管理，推动了对输液帮浦的需求。

全球人口老化进一步加速了输液帮浦的普及，尤其是在门诊病人和居家照护环境中，以便为需要接受复杂药物治疗的老年患者提供安全且精准的药物输送。世界卫生组织 (WHO) 报告称，2024 年出生时的平均寿命将达到 73.3 岁，比 1995 年增加 8.4 岁。此外，预计到 2030 年，全球 60 岁及以上人口将从 2023 年的 11 亿增加到 14 亿，这凸显了对此类技术日益增长的需求。

输液帮浦技术进步显着推动了市场需求。智慧型输液帮浦具备无线连接、电子病历整合和自动编程功能，可最大限度地减少用药错误，简化工作流程，进而提高病人安全性和业务效率。

静脉输液帮浦市场亮点：

  • 2024 年，定量输液帮浦占据了各产品领域最大的市场占有率。其精确输送大量液体的有效性对于癌症和糖尿病等慢性疾病的治疗以及外科手术至关重要。
  • 预计胰岛素输注帮浦在预测​​期内将以超过9.0%的复合年增长率快速成长。全球糖尿病盛行率不断上升，主要原因是人口老化、不健康的生活方式以及肥胖率的上升，这推动了胰岛素帮浦的需求。
  • 小儿科/新生儿科在疾病适应症领域占据主导地位，占 2024 年总收入份额的 25.0% 以上。
  • 由于癌症患者数量的增加和癌症治疗药物的快速发展，预计化疗领域在预测期内将以最快的复合年增长率增长。
  • 由于先进的医疗基础设施、日益​​增多的慢性病以及技术进步，北美在静脉输液泵市场占据主导地位。
  • 2024年5月，穆格公司（Moog Inc.）的CURLIN 8,000门诊输液系统获得FDA 510(k)认证。这款全新的多疗法平台旨在提升家庭输液环境中的易用性和安全性。

目录

第一章调查方法与范围

第二章执行摘要

第三章静脉输液帮浦市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 静脉输液帮浦市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析
  • 静脉输液帮浦市场：渠道分析

第四章静脉输液帮浦市场：产品评估与趋势分析

  • 产品细分仪表板
  • 静脉输液帮浦市场：产品差异分析
  • 全球静脉输液帮浦市场规模及趋势分析（依产品，2018-2030）
  • 容积式输液泵
  • 注射输液帮浦
  • 胰岛素输注泵
  • 肠内输液泵
  • 携带式输液泵
  • 病人自控镇痛输液泵
  • 植入式输液泵
  • 其他的

第五章静脉输液帮浦市场：疾病适应症评估与趋势分析

  • 疾病适应症细分仪表板
  • 静脉输液帮浦市场：疾病适应症变异分析
  • 全球静脉输液帮浦市场规模及趋势分析（依疾病适应症，2018-2030年）
  • 化疗
  • 糖尿病
  • 胃肠病学
  • 镇痛/疼痛管理
  • 小儿科/新生儿科
  • 血液学
  • 其他的

6. 静脉输液帮浦市场：区域估计与趋势分析

  • 区域市场仪表板
  • 2024 年及 2030 年区域市场占有率分析
  • 静脉输液帮浦市场各地区概况及要点
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 2024年主要企业热图分析
  • 公司简介
    • Baxter
    • B. Braun Medical Inc.
    • Medtronic
    • Micrel Medical Devices SA
    • Boston Scientific Corporation
    • Cardinal Health
    • Fresenius Kabi AG
    • ICU Medical, Inc.
    • F. Hoffmann-La Roche Ltd
    • Tandem Diabetes Care, Inc.
    • Terumo Corporation
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Moog Inc.
    • IRadimed Corporation
Product Code: GVR-4-68038-560-1

Intravenous Infusion Pumps Market Growth & Trends:

The global intravenous infusion pumps market size is anticipated to reach USD 9.98 billion by 2030 and is anticipated to expand at a CAGR of 8.5% during the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic conditions, including cancer, diabetes, cardiovascular, and respiratory diseases, necessitates precise medication and therapy administration, thereby driving the demand for infusion pumps.

The global aging population further amplifies the adoption of infusion pumps, particularly in outpatient and home care settings, where they facilitate safe and accurate drug delivery for elderly patients managing complex medication regimens. The World Health Organization reported that life expectancy at birth increased to 73.3 years in 2024, a rise of 8.4 years since 1995. Moreover, the global population aged 60 and older is projected to reach 1.4 billion by 2030, up from 1.1 billion in 2023, highlighting the growing need for such technologies.

Technological advancements in infusion pump capabilities significantly bolster market demand. Smart infusion pumps, featuring wireless connectivity, EHR integration, and automated programming, enhance patient safety and operational efficiency by minimizing medication errors and streamlining workflows

Intravenous Infusion Pumps Report Highlights:

  • Volumetric infusion pumps held the largest market share in the product segment in 2024. Their efficacy in delivering large volumes precisely is vital in managing chronic diseases such as cancer and diabetes and in surgical procedures.
  • Insulin infusion pumps are projected to grow at the fastest CAGR of over 9.0% over the forecast period. The global rise in diabetes prevalence, primarily due to aging populations, unhealthy lifestyles, and increasing obesity rates, has driven insulin pump demand.
  • Pediatrics/neonatology dominated the disease indication segment with over 25.0% of the total revenue share in 2024.
  • The chemotherapy segment is projected to grow at the fastest CAGR over the forecast period, driven by the rising number of cancer cases and rapid development in oncological drugs.
  • North America dominated the intravenous infusion pumps market due to its advanced medical infrastructure, increasing chronic disease prevalence, and technological advancements.
  • In May 2024, Moog Inc. received FDA 510(k) clearance for its CURLIN 8000 Ambulatory Infusion System. This new multi-therapy platform was designed for enhanced usability and safety in home infusion settings.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Disease Indication
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Disease indication outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Intravenous Infusion Pumps Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Intravenous Infusion Pumps Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Intravenous Infusion Pumps Market: Pipeline Analysis

Chapter 4. Intravenous Infusion Pumps Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Intravenous Infusion Pumps Market: Product Movement Analysis
  • 4.3. Global Intravenous Infusion Pumps Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Volumetric Infusion Pumps
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Syringe Infusion Pumps
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Insulin Infusion Pumps
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Enteral Infusion Pumps
    • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Ambulatory Infusion Pumps
    • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Patient-Controlled Analgesia Infusion Pumps
    • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10. Implantable Infusion Pumps
    • 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.11. Others
    • 4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Intravenous Infusion Pumps Market: Disease Indication Estimates & Trend Analysis

  • 5.1. Disease Indication Segment Dashboard
  • 5.2. Intravenous Infusion Pumps Market: Disease Indication Movement Analysis
  • 5.3. Global Intravenous Infusion Pumps Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
  • 5.4. Chemotherapy
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Diabetes
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Gastroenterology
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Analgesia/Pain Management
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Pediatrics/Neonatology
    • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Hematology
    • 5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.10. Others
    • 5.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Intravenous Infusion Pumps Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Intravenous infusion pumps market by Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Denmark
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Norway
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework/ reimbursement structure
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. China
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Australia
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Argentina
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. South Africa
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. UAE
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.4. Kuwait
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Regulatory framework/ reimbursement structure
      • 6.8.4.3. Competitive scenario
      • 6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Baxter
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. B. Braun Medical Inc.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Medtronic
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Micrel Medical Devices SA
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Boston Scientific Corporation
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Cardinal Health
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Fresenius Kabi AG
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. ICU Medical, Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. F. Hoffmann-La Roche Ltd
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Tandem Diabetes Care, Inc.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Terumo Corporation
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives
    • 7.4.13. Moog Inc.
      • 7.4.13.1. Company overview
      • 7.4.13.2. Financial performance
      • 7.4.13.3. Product benchmarking
      • 7.4.13.4. Strategic initiatives
    • 7.4.14. IRadimed Corporation
      • 7.4.14.1. Company overview
      • 7.4.14.2. Financial performance
      • 7.4.14.3. Product benchmarking
      • 7.4.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global intravenous infusion pumps market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 5 North America intravenous infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 7 North America intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 8 U.S. intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 10 Canada intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 12 Mexico intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico surgical ablation market, by disease indication, 2018 - 2030 (USD Million)
  • Table 14 Europe intravenous infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 15 Europe intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 16 Europe intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 17 UK intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 18 UK intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 19 Germany intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 21 France intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 22 France intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 23 Italy intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 24 Italy intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 25 Spain intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 26 Spain intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 27 Denmark intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 28 Denmark intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 29 Sweden intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 30 Sweden intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 31 Norway intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 32 Norway intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific intravenous infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 36 China intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 37 China intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 38 Japan intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 39 Japan intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 40 India intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 41 India intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 42 Australia intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 43 Australia intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 44 South Korea intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 45 South Korea intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 46 Thailand intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 47 Thailand intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 48 Latin America intravenous infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 49 Latin America intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 50 Latin America laparoscopic ablation market, by disease indication, 2018 - 2030 (USD Million)
  • Table 51 Latin America percutaneous ablation market, by disease indication, 2018 - 2030 (USD Million)
  • Table 52 Latin America intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 53 Brazil intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 54 Brazil surgical ablation market, by disease indication, 2018 - 2030 (USD Million)
  • Table 55 Argentina intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 56 Argentina surgical ablation market, by disease indication, 2018 - 2030 (USD Million)
  • Table 57 MEA intravenous infusion pumps market, by region, 2018 - 2030 (USD Million)
  • Table 58 MEA intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 59 MEA intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 60 South Africa intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 61 South Africa intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 63 Saudi Arabia intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 64 UAE intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 65 UAE intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 66 Kuwait intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 67 Kuwait intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Intravenous infusion pumps market: market outlook
  • Fig. 10 Intravenous infusion pumps competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Intravenous infusion pumps market driver impact
  • Fig. 16 Intravenous infusion pumps market restraint impact
  • Fig. 17 Intravenous infusion pumps market strategic initiatives analysis
  • Fig. 18 Intravenous infusion pumps market: Product movement analysis
  • Fig. 19 Intravenous infusion pumps market: Product outlook and key takeaways
  • Fig. 20 Volumetric infusion pumps estimates and forecast, 2018 - 2030
  • Fig. 21 Syringe infusion pumps estimates and forecast, 2018 - 2030
  • Fig. 22 Insulin infusion pumps estimates and forecast, 2018 - 2030
  • Fig. 23 Enteral infusion pumps estimates and forecast, 2018 - 2030
  • Fig. 24 Ambulatory infusion pumps estimates and forecast, 2018 - 2030
  • Fig. 25 Patient-controlled analgesia infusion pumps estimates and forecast, 2018 - 2030
  • Fig. 26 Implantable infusion pumps estimates and forecast, 2018 - 2030
  • Fig. 27 Others estimates and forecast, 2018 - 2030
  • Fig. 28 Intravenous infusion pumps market: Disease indication movement analysis
  • Fig. 29 Intravenous infusion pumps market: Disease indication outlook and key takeaways
  • Fig. 30 Chemotherapy estimates and forecast, 2018 - 2030
  • Fig. 31 Diabetes estimates and forecast, 2018 - 2030
  • Fig. 32 Gastroenterology estimates and forecast, 2018 - 2030
  • Fig. 33 Analgesia/pain management estimates and forecast, 2018 - 2030
  • Fig. 34 Pediatrics/neonatology estimates and forecast, 2018 - 2030
  • Fig. 35 Hematology estimates and forecast, 2018 - 2030
  • Fig. 36 Others estimates and forecast, 2018 - 2030
  • Fig. 37 Global intravenous infusion pumps market: Regional movement analysis
  • Fig. 38 Global intravenous infusion pumps market: Regional outlook and key takeaways
  • Fig. 39 North America market estimates and forecasts, 2018 - 2030
  • Fig. 40 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 41 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 42 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 43 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 44 UK market estimates and forecasts, 2018 - 2030
  • Fig. 45 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 46 France market estimates and forecasts, 2018 - 2030
  • Fig. 47 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 48 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 49 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 50 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 51 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 52 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 53 China market estimates and forecasts, 2018 - 2030
  • Fig. 54 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 55 India market estimates and forecasts, 2018 - 2030
  • Fig. 56 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 57 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 58 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 59 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 60 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 61 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 62 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 63 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 64 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 65 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 66 Kuwait market estimates and forecasts, 2018 - 2030